BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9015068)

  • 21. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
    Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
    Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of dynamic MR imaging of the breast and sestamibi scintimammography for evaluation of indeterminate mammographic lesions.
    Leinsinger GL; Friedl L; Tiling R; Scherr MK; Heiss DT; Kandziora C; Camerer B; Sommer H; Pfluger T; Hahn K
    Eur Radiol; 2001; 11(10):2050-7. PubMed ID: 11702141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
    Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
    AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scintimammography with a hybrid SPECT/CT imaging system.
    Schillaci O; Danieli R; Filippi L; Romano P; Cossu E; Manni C; Simonetti G
    Anticancer Res; 2007; 27(1B):557-62. PubMed ID: 17348441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.
    Mahfouz AE; Hamm B; Wolf KJ
    Radiology; 1994 Jan; 190(1):49-52. PubMed ID: 8259426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.
    Tiling R; Tatsch K; Sommer H; Meyer G; Pechmann M; Gebauer K; Münzing W; Linke R; Khalkhali I; Hahn K
    J Nucl Med; 1998 May; 39(5):849-56. PubMed ID: 9591588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Delpassand ES; Jackson EF
    Radiology; 1997 Oct; 205(1):283-4; author reply 285-6. PubMed ID: 9315002
    [No Abstract]   [Full Text] [Related]  

  • 28. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography.
    Tiling R; Khalkhali I; Sommer H; Linke R; Moser R; Willemsen F; Pfluger T; Tatsch K; Hahn K
    Nucl Med Commun; 1998 Jan; 19(1):55-62. PubMed ID: 9515547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-photon-emission computed tomography (SPECT) with technetium-99m sestamibi in the diagnosis of small breast cancer and axillary lymph node involvement.
    DeCesare A; De Vincentis G; Gervasi S; Crescentini G; Fiori E; Bonomi M; Crocetti A; Sterpetti AV
    World J Surg; 2011 Dec; 35(12):2668-72. PubMed ID: 22002494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement.
    Schillaci O; Scopinaro F; Danieli R; Tavolaro R; Picardi V; Cannas P; Colella AC
    Nucl Med Commun; 1997 Sep; 18(9):839-45. PubMed ID: 9352550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
    Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
    Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms.
    Tiling R; Khalkhali I; Sommer H; Moser R; Meyer G; Willemsen F; Pfluger T; Tatsch K; Hahn K
    Eur J Nucl Med; 1997 Oct; 24(10):1221-9. PubMed ID: 9323262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard.
    Chen SL; Yin YQ; Chen JX; Sun XG; Xiu Y; Liu WG; Liu M; Zhu WM; Zhang YB
    Anticancer Res; 1997; 17(3B):1695-8. PubMed ID: 9179221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
    Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
    Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
    Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
    J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.
    Gribbestad IS; Nilsen G; Fjøsne HE; Kvinnsland S; Haugen OA; Rinck PA
    J Magn Reson Imaging; 1994; 4(3):477-80. PubMed ID: 8061451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
    Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Servais F; Blocklet DC; Seret AE; Lenaers A; Schoutens AC
    Radiology; 1997 Oct; 205(1):283; author reply 285-6. PubMed ID: 9315001
    [No Abstract]   [Full Text] [Related]  

  • 40. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
    Palmedo H; Schomburg A; Grünwald F; Mallmann P; Krebs D; Biersack HJ
    J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.